Therapy‐related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks
Malcolm A. Smith(National Cancer Institute), Richard S. Ungerleider(Unknown), Larry Rubinstein(National Cancer Institute)
Cited by 178
Related Papers
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
|Journal of Clinical Oncology|1996|914
How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials
|Journal of Clinical Oncology|2002|531
The genomic landscape of pediatric acute lymphoblastic leukemia
|Nature Genetics|2022|394